Toll-like receptor 4 (TLR4) is a transmembrane protein recognizing lipopolysaccharide (LPS), extra domain A of fibronectin, and heat shock protein 60 (Hsp60) as ligands. [1] [2] [3] Cytoplasmic domain of TLR4 is similar to interleukin-1 receptor.
Cytoplasmic domain of TLR4 is similar to interleukin-1 receptor. 4) Signaling components downstream TLR4 include myeloid differentiation 88 (MyD88), interleukin-1 receptorassociated kinase (IRAK), and tumor necrosis factor receptor-associated factor 6 (TRAF6), which finally activate nuclear factor (NF)-kB. 5, 6) Nitric oxide (NO) is a free radical gas produced from L-arginine by catalytic reaction of NO synthase (NOS). Endothelial NOS-derived NO is involved in physiological regulation of blood pressure by acting as a vasodilator, whereas NO produced by neuronal NOS is associated with neurotransmission. 7, 8) Macrophages can also produce NO for destroying invading microorganisms through expression of inducible NOS (iNOS) in response to bacterial LPS and proinflammatory cytokines. 9, 10) iNOS is capable of producing much larger amounts of NO than endothelial or neuronal NOS. However, it is also evidenced that iNOS induction can be happened not only in a variety of other cell types including vascular smooth muscle and neuronal cells, but also that high-output NO may provoke deleterious consequences such as septic shock, autoimmune disorders and inflammatory diseases. [11] [12] [13] iNOS expression in macrophages is under control of several transcription factors including NF-kB. 14, 15) NF-kB is sequestered in the cytoplasm, binding to inhibitory kB (IkB) proteins. TLR4-mediated signaling components can activate IkB kinase (IKK) complex, which results in phosphorylation of IkB followed by proteasome-mediated degradation. 5, 6) NF-kB, free of IkB, is now moved to the nucleus and then binds to the promoter region of immune and inflammatory genes including iNOS for transcriptional regulation. 16, 17) In our random screening study to discover anti-inflammatory agents, synthetic N 1 -benzyl-4-methylbenzene-1,2-diamine (BMD compound, Fig. 1 ) was found to inhibit NO production in macrophages RAW 264.7 stimulated with LPS or fibronectin as TLR4 activators. In this study, inhibitory effects of BMD compound on iNOS expression and NF-kB activation in addition to NO production have been investigated.
MATERIALS AND METHODS

Materials and Cell
Culture LPS (E. coli 055:B5) and fibronectin (bovine plasma) were purchased from SigmaAldrich (St. Louis, MO), and fetal bovine serum (FBS) from Invitrogen (Carlsbad, CA, U.S.A.). Chemical preparation of BMD compound (purity, Ͼ98%) was described elsewhere. 18) Macrophages RAW 264.7 were cultured in DMEM (13.4 mg/ml Dulbecco's modified Eagle's medium, 24 mM NaHCO 3 , 10 mM HEPES, 143 U/ml benzylpenicillin potassium, 100 mg/ml streptomycin sulfate, pH 7.1) containing 10% FBS and maintained at 37°C with 5% CO 2 . The RAW 264.7 cells harboring pNF-kB-secretory alkaline phosphatase (SEAP)-NPT construct 19) were grown in the same conditions except supplement of 500 mg/ ml geneticin to the media.
Nitrite Quantification Macrophages RAW 264.7 were pre-treated with BMD compound for 2 h, and stimulated with either LPS (1 mg/ml) or fibronectin (30 mg/ ml) for 24 h. Nitrite content in the cell-free culture media was measured using Griess reagent. 20) Briefly, cell-free culture media (100 ml) was reacted with 1 : 1 mixture (100 ml) of 1% sulfanilamide in 5% H 3 PO 4 and 0.1% N-(1-naphthyl)ethylenediamine in distilled water, and then absorbance at 540 nm was measured.
Western Blot Analysis Macrophages RAW 264.7 were pre-treated with BMD compound for 2 h, and stimulated with LPS (1 mg/ml) for 18 h. Lysates of the cells were subjected to Western immunoblot analysis with anti-iNOS antibody as described in our previous work.
21 ) The blots were finally reacted with ECL detection reagents (Amersham-Pharmacia, San Francisco, CA, U.S.A.) and exposed to X-ray film.
Semi were pre-treated with BMD compound for 2 h, and stimulated with LPS (1 mg/ ml) for 6 h. Total RNA of the cells were subjected to RT-PCR for iNOS transcript using an RNA PCR kit (Bioneer, Daejeon, Korea) as described in our previous work.
21 ) The RT-PCR products were resolved on 1.5% agarose gel by electrophoresis and then stained with ethidium bromide.
Measurement of iNOS Promoter Activity Macrophages RAW 264.7 were transiently transfected with both iNOS-luciferase reporter plasmid 14) and pSV-b-galactosidase control vector (Promega, Madison, WI, U.S.A.) using Lipofect-AMINE TM (Invitrogen, Carlsbad, CA, U.S.A.). The transfected RAW 264.7 cells were pre-treated with BMD compound for 2 h, and stimulated with LPS (1 mg/ ml) or fibronectin (30 mg/ ml) for 24 h. Lysates of the cells were measured for luciferase activity using Luciferase Reporter Assay System (Promega, Madison, WI, U.S.A.) and for bgalactosidase activity using b-Galactosidase Enzyme Assay System (Promega, Madison, WI, U.S.A.).
Measurement of NF-k kB Transcriptional Activity NFkB transcriptional activity was monitored using macrophages RAW 264.7 transfected stably with pNF-kB-SEAP-NPT reporter construct.
19) The transfected RAW 264.7 cells were pre-treated with BMB compound for 2 h, and stimulated with either LPS (1 mg/ml) or fibronectin (30 mg/ml) for 24 h. Aliquots of the cell-free culture media were heated at 65°C for 5 min, and reacted with SEAP assay buffer (2 M diethanolamine, 1 mM MgCl 2 ) containing 500 mM 4-methylumbelliferyl phosphate in the dark for 1 h. Fluorescence was measured as relative fluorescence units (RFU) with emission 449 nm and excitation 360 nm.
Cytotoxicity Measurement Macrophages RAW 264.7 were incubated with various concentrations of BMD compound for 24 h. The cells were treated with WST-1 as described in our previous work, 22) and absorbance at 450 nm was measured.
Statistical Analysis Results are expressed as meanϮ S.E.M. Data were analyzed by ANOVA followed by the Dunnet test. Values of pϽ0.01 were considered significant.
RESULTS AND DISCUSSION
In this study, synthetic BMD compound (Fig. 1 ) was found to inhibit NO production in macrophages RAW 264.7 stimulated with LPS or fibronectin as TLR4 activators. Macrophages RAW 264.7 in resting state released 9.5 mM of nitrite, a stable NO metabolite, during incubation for 24 h (Fig. 2) . No significant difference in NO production was found between resting RAW 264.7 cells and the cells treated with BMD compound (30 mM) alone (Fig. 2A) . The RAW 264.7 cells treated with LPS alone markedly increased NO production to 61.2 mM of nitrite ( Fig. 2A) . BMD compound inhibited LPS-induced nitrite release in a dose-dependent manner with an IC 50 value of 9.2 mM (Fig. 2A) . Treatment of fibronectin, another TLR4 activator, to the RAW 264.7 cells increased NO production to 23.3 mM of nitrite (Fig. 2B) . The fibronectin-induced nitrite release was also inhibited by BMD compound in a dose-dependent manner with an IC 50 value of 3.4 mM (Fig. 2B) . BMD compound (1-30 mM) did not show any cytotoxic effects to the RAW 264.7 cells (Fig. 3) .
To investigate whether inhibitory effect of BMD compound on NO production was attributable to its influence on iNOS expression, Western immunoblot analysis was carried out. iNOS protein was hardly detectable in resting macrophages RAW 264.7, but pronounced amounts of iNOS protein were induced upon exposure to LPS alone (Fig. 4A) . Treatment of BMD compound to RAW 264.7 cells decreased LPS-induced synthesis of iNOS protein in a dose-dependent manner with an IC 50 value of 6.3 mM (Fig. 4A) . However, synthesis of housekeeping glyceraldehydes-3-phosphate dehydrogenase (GAPDH) was not affected by treatment of LPS and/or BMD compound (Fig. 4A) . Semi-quantitative RT-PCR was also carried out to investigate whether BMD compound can affect LPS-induced synthesis of iNOS transcript. Amounts of iNOS transcript were markedly increased by treatment of macrophages RAW 264.7 to LPS alone (Fig. 4B) . BMD compound inhibited LPS-induced synthesis of iNOS transcript in a dose-dependent manner with an IC 50 value of 10.9 mM (Fig. 4B) . However, synthesis of housekeeping b-actin was not affected by treatment of LPS and/or BMD compound (Fig. 4B) .
Transcriptional control of iNOS expression by BMD compound was further documented using a promoter activity, which was analyzed in macrophages RAW 264.7 transfected transiently with iNOS-luciferase plasmid containing murine iNOS promoter (Ϫ1592/ϩ183) fused to luciferase gene as a reporter. 14) Treatment of LPS alone to the transfected cells increased luciferase expression to 36-fold over the basal level, and BMD compound inhibited LPS-induced luciferase expression in a dose-dependent manner with an IC 50 value of 6.4 mM (Fig. 5A) . No significant difference in luciferase expression was found between transfected RAW 264.7 cells in resting state and the cells treated with BMD compound (30 mM) alone (Fig. 5A) . Fibronectin also increased the luciferase expression to 12-fold over the basal level, and BMD compound inhibited fibronectin-induced luciferase expression in a dose-dependent manner with an IC 50 value of 5.1 mM (Fig. 5B) .
NF-kB transcription factor has been evidenced to play an important role in TLR4-mediated expression of iNOS in macrophages.
9,10) NF-kB transcriptional activity was monitored using macrophages RAW 264.7 transfected stably with pNF-kB-SEAP-NPT construct containing four copies of kB sequence fused to SEAP gene as a reporter. 18) Treatment of LPS alone to RAW 264.7 cells harboring pNF-kB-SEAP-NPT increased SEAP expression to 3-4 fold over the basal level, indicating that cellular NF-kB is transcriptionally functional (Fig. 6A) . BMD compound exhibited dose-dependent inhibitory effects with an IC 50 value of 8.5 mM on LPSinduced SEAP expression (Fig. 6A) . No significant difference in SEAP expression was found between the resting RAW 264.7 cells and the cells treated with BMD compound (30 mM) alone (Fig. 6A) . Fibronectin also increased the SEAP expression to 2-3 fold over the basal level, and BMD compound inhibited fibronectin-induced SEAP expression in a dose-dependent manner with an IC 50 value of 4.1 mM (Fig. 6B) .
In the present study, both LPS and fibronectin, TLR4 activators, increased not only NO production via up-regulation of iNOS expression but also NF-kB transcriptional activity in macrophages RAW 264.7. BMD compound down-regulated TLR4-mediated iNOS expression at transcription level and inhibited NF-kB activation. A structural analog of BMD compound, 4-methyl-N 1 -(3-phenylpropyl)-benzene-1,2-diamine was reported to its inhibitory action on nuclear translocation of NF-kB p65 without IkB degradation in LPS-stimulated macrophages RAW 264.7.
23) Finally, BMD compound could provide an invaluable tool to investigate TLR4-mediated iNOS expression and NF-kB activation, in addition to its therapeutic potential in NO-associated autoimmune and inflammatory diseases. pNF-kB-SEAP-NPT and iNOS-luciferase reporter construct, respectively.
